About The Evidence Base®

The Evidence Base® is a free-to-access online hub providing the latest news, opinions and insights into hot topics including real-world data, health economics and outcomes research, and much more.

Through partnership with our sister journal, the Journal of Comparative Effectiveness Research, we seek to educate and inspire to help this exciting field move forward at an even faster rate.

About the Journal

The peer-reviewed Journal of Comparative Effectiveness Research (ISSN: 2042-6305) provides a rapid-publication platform for debate and the presentation of new findings and research methodologies.

Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders – including patients, clinicians, healthcare purchasers and health policy makers – with the key data and opinions to make informed and specific decisions on clinical practice.

Registered members of The Evidence Base have free access to select content from the Journal of Comparative Effectiveness Research.

Articles published in the Journal of Comparative Effectiveness Research cover key areas such as:

  • Studies of patient-centered outcomes, effectiveness or comparative effectiveness yielding new findings relating to diagnostics, therapeutics, surgical procedures, or other healthcare services or options
  • Systematic reviews of available evidence relating to the pros and cons of healthcare options for specific patient groups, including precision medicine and comparative safety
  • Perspectives and debate relating to the methodology of comparative effectiveness studies and best practice issues
  • Commentary on both patient-relevant outcomes and economic implications
  • Real-world evidence assessing the comparative safety and effectiveness of existing and new treatment strategies
  • Direct ‘head-to-head’ comparisons of available diagnostic and therapeutic options – evaluating the performance of clinical alternatives against current standards of care
  • Evaluation and interpretation of the findings of recently completed comparative effectiveness trials, as well as articles discussing the design and rationale of newly commenced studies
  • Pharmacoeconomic, health economics and outcomes research studies

For more details, please see here or contact the journal’s Commissioning Editor, Laura Dormer.

About Future Science Group

Future Science Group (London, UK), founded in 2001, is independently owned. Future Science Group’s portfolio consists of two imprints, Future Medicine Ltd. and Future Science Ltd., both of which publish books and journals. In addition to this core publishing business, Future Science Group develops specialist community-driven websites. Key titles and sites include Oncology Central, RegMedNet and the award-winning Regenerative Medicine.

The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.


The opinions expressed on The Evidence Base are those of the authors/interviewees and do not necessarily reflect the views of The Evidence Base, Future Medicine Ltd. or any of its affiliates.


The people behind The Evidence Base

Meet the team
Darcy Hodge (she/her)
Freya Leask (she/her)
Laura Dormer (she/her)
Editorial Director
Joanne Walker (she/her)
Head of Publishing Solutions
Amy Bamford (she/her)
Business Development Manager